Transcription factor EGR3 is involved in the estrogen-signaling pathway in breast cancer cells

Journal of Molecular Endocrinology

Volumn 32, Issue 3, 2004, Pages 649-661

  Inoue, A ^a,b   Omoto, Y ^a   Yamaguchi, Y ^a   Kiyama, R ^b,c   Hayashi, Shin I ^a  

^a Saitama Cancer Centre Research Inst   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^c InfoGenes Co Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLOHEXIMIDE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; FAS LIGAND; FULVESTRANT; TRANSCRIPTION FACTOR; ZINC FINGER PROTEIN;

ARTICLE; BREAST CANCER; CANCER CELL; CARCINOGENESIS; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA MICROARRAY; DOWNSTREAM PROCESSING; ESTROGEN ACTIVITY; EXPRESSION VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNE SYSTEM; MALIGNANT TRANSFORMATION; MOLECULAR MECHANICS; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; CELL LINE, TUMOR; CYCLOHEXIMIDE; EARLY GROWTH RESPONSE PROTEIN 3; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FAS LIGAND PROTEIN; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; MEMBRANE GLYCOPROTEINS; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS (GENETICS); PROTEIN SYNTHESIS INHIBITORS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 3042717657     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.0.0320649     Document Type: Article

References (38)

1. Anderson E, Clarke RB & Howell A 1998 Estrogen responsiveness and control of normal human breast proliferation. Journal of Mammary Gland Biology and Neoplasia 3 23-35.
2. Bouras T, Southey MC, Chang AC, Reddel RR, Willhite D, Glynne R, Henderson MA, Armes JE & Venter DJ 2002 Stanniocalcin 2 is an estrogen-responsive gene coexpressed with the estrogen receptor in human breast cancer. Cancer Research 62 1289-1295.
3. Brown AM, Jeltsch JM, Roberts M & Chambon P 1984 Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. PNAS 81 6344-6348.
4. Chomczynski P & Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 162 156-159.
5. Duan R, Porter W, Samudio I, Vyhlidal C, Kladde M & Safe S 1999 Transcriptional activation of c-fos protooncogene by 17 beta-estradiol: mechanism of aryl hydrocarbon receptor-mediated inhibition. Molecular Endocrinology 13 1511-1521.
6. Fanelli MA, Vargas-Roig LM, Gago FE, Tello O, Lucero De Angelis R & Ciocca DR 1996 Estrogen receptors, progesterone receptors, and cell proliferation in human breast cancer. Breast Cancer Research and Treatment 37 217-228.
7. Finlin BS, Gau C-L, Murphy GA, Shao H, Kimel T, Seitz RS, Chiu Y-F, Botstein D, Brown PO, Der CJ, Tamanoi F, Andres DA & Perou CM 2001 RERG is a novel ras-related, estrogen-regulated and growth-inhibitory gene in breast cancer. Journal of Biological Chemistry 276 42259-42267.
8. Gashler A & Sukhatme VP 1995 Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. Progress in Nucleic Acid Research and Molecular Biology 50 191-224.
9. Gutierrez LS, Eliza M, Niven-Fairchild T, Naftolin F & Mor G 1999 The Fas/Fas-ligand system: a mechanism for immune evasion in human breast carcinomas. Breast Cancer Research and Treatment 54 245-253.
10. Hayashi S, Imai K, Suga K, Kurihara T, Higashi Y & Nakachi K 1997 Two promoters in expression of estrogen receptor messenger RNA in human breast cancer. Carcinogenesis 18 459-464.
11. Holtz-Heppelmann CJ, Algeciras A, Badley AD & Paya CV 1998 Transcriptional regulation of the human FasL promoter-enhancer region. Journal of Biological Chemistry 273 4416-4423.
12. Ikeda K, Orimo A, Higashi Y, Muramatsu M & Inoue S 2000 Efp as a primary estrogen-responsive gene in human breast cancer. FFBS Letters 472 9-13.
13. Inoue A, Yoshida N, Omoto Y, Oguchi S, Yamori T, Kiyama R & Hayashi S 2002 Development of cDNA microarray for expression profiling of estrogen-responsive genes. Journal of Molecular Endocrinology 29 175-192.
14. Jouvert P, Dietrich JB, Aunis D & Zwiller J 2002 Differential rat brain expression of EGR proteins and of the transcriptional corepressor NAB in response to acute or chronic cocaine administration. Neuromolecular Medicine 1 137-151.
15. Kirsch KH, Korradi Y & Johnson JP 1996 Mader: a novel nuclear protein over expressed in human melanomas. Oncogene 12 963-971.
16. Mages HW, Stamminger T, Rilke O, Bravo R & Kroczek RA 1993 Expression of PILOT, a putative transcription factor, requires two signals and is cyclosporin A sensitive in T cells. International Immunology 5 63-70.
17. Masiakowski P, Breathnach R, Bloch J, Gannon F, Krust A & Chambon P 1982 Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Research 10 7895-7903.
18. Mercier G, Turque N & Schumacher M 2001 Early activation of transcription factor expression in Schwann cells by progesterone. Brain Research. Molecular Brain Research 97 137-148.
19. Mittelstadt PR & Ashwell JD 1998 Cyclosporin A-sensitive transcription factor Egr-3 regulates Fas ligand expression. Molecular and Cellular Biology 18 3744-3751.
20. O'Donovan KJ, Wilkens EP & Baraban JM 1998 Sequential expression of Egr-1 and Egr-3 in hippocampal granule cells following electroconvulsive stimulation. Journal of Neurochemistry 70 1241-1248.
21. O'Donovan KJ, Tourtellotte WG, Millbrandt J & Baraban JM 1999 The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuroscience. Trends in Neurosciences 22 167-173.
22. Ozaki K, Nagata M, Suzuki M, Fujiwara T, Ueda K, Miyoshi Y, Takahashi E & Nakamura Y 1998 Isolation and characterization of a novel human lung-specific gene homologous to lysosomal membrane glycoproteins 1 and 2: significantly increased expression in cancers of various tissues. Cancer Research 58 3499-3503.
23. Pike MC, Spicer DV, Dahmoush L & Press MF 1993 Estrogens, progesterones, normal breast cell proliferation, and breast cancer risk. Epidemiologic Reviews 15 17-35.
24. Prest SJ, May FE & Westley BR 2002 The estrogen-regulated protein, TFF1, stimulates migration of human breast cancer cells. FASEB Journal 16 592-594.
25. Qu Z, Wolfraim LA, Svaren J, Ehrengruber MU, Davidson N & Milbrandt J 1998 The transcriptional corepressor NAB2 inhibits NGF-induced differentiation of PC12 cells. Journal of Cell Biology 142 1075-1082.
26. Rabinowich H, Reichert TE, Kashii Y, Gastman BR, Bell MC & Whiteside TL 1998 Lymphocyte apoptosis induced by Fas ligand-expressing ovarian carcinoma cells. Implications for altered expression of T cell receptor in tumor-associated lymphocytes. Journal of Clinical Investigation 101 2579-2588.
27. Russo MW, Sevetson BR & Milbrandt J 1995 Identification of NAB1, a repressor of NGFI-A- and Krox20-mediated transcription. PNAS 92 6873 6877.
28. Sevetson BR, Svaren J & Milbrandt J 2000 A novel activation function for NAB proteins in EGR-dependent transcription of the luteinizing hormone beta gene. Journal of Biological Chemistry 275 9749-9757.
29. Shoker BS, Jarvis C, Sibson DR, Walker C & Sloane JP 1999 Oestrogen receptor expression in the normal and pre-cancerous breast. Journal of Pathology 188 237-244.
30. Soulez M & Parker MG 2001 Identification of novel oestrogen receptor target genes in human ZR75-1 breast cancer cells by expression profiling. Journal of Molecular Endocrinology 27 259-274.
31. Stack G, Kumar V, Green S, Ponglikitmongkol M, Berry M, Rio MC, Nunez AM, Roberts M, Koehl C & Bellocq P 1988 Structure and function of the pS2 gene and estrogen receptor in human breast cancer cells. Cancer Treatment and Research 40 185-206.
32. Suggs SV, Katzowitz JL, Tsai-Morris C & Sukhatme VP 1990 cDNA sequence of the human cellular early growth response gene Egr-1. Nucleic Acids Research 25 4283.
33. Svaren J, Sevetson BR, Apel ED, Zimonjic DB, Popescu NC & Milbrandt J 1996 NAB2, a corepressor of NGFI-A (Egr-1) and Krox20, is induced by proliferative and differentiative stimuli. Molecular and Cellular Biology 16 3545-3553.
34. Tourtellotte WG & Milbrandt J 1998 Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. Nature Genetics 20 87-91.
35. Tourtellotte WG, Keller-Peck C, Milbrandt J & Kucera J 2001 The transcription factor Egr3 modulates sensory axon-myotube interactions during muscle spindle morphogenesis. Development of Biology 232 388-399.
36. Urano T, Saito T, Tsukui T, Fujita M, Hosoi T, Muramatsu M, Ouchi Y & Inoue S 2002 Efp targets 14-13-3 sigma for proteolysis and promotes breast tumour growth. Nature 417 871-875.
37. Wang D, Mayo MW & Baldwin AS Jr 1997 Basic fibroblast growth factor transcriptional autoregulation requires EGR-1. Oncogene 14 2291-2299.
38. Westley B & Rochefort H 1980 A secreted glycoprotein induced by estrogen in human breast cancer cell lines. Cell 20 353-362.